NCT00242944View on ClinicalTrials.gov

Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

PHASE4CompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

March 31, 2008

Conditions
Coronary DiseaseHypercholesterolemia
Interventions
DRUG

Pitavastatin

Pitavastatin 4mg per day

DRUG

Atorvastatin

Atorvastatin 20mg per day

Trial Locations (3)

113-8421

Juntendo University School of Medicine, Bunkyo-ku

755-8505

Yamaguchi University Graduate School of Medicine, Ube

606-8507

Kyoto University Graduate School of Medicine, Kyoto

All Listed Sponsors
collaborator

Yamaguchi University Hospital

OTHER

collaborator

Juntendo University

OTHER

lead

Kyoto University

OTHER

NCT00242944 - Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS) | Biotech Hunter | Biotech Hunter